Pros and cons of GLP-1 agonists and DPP-IV inhibitors

被引：0
|
作者：
Toft, Anders Dyhr [1 ]
机构：
[1] Novo Nordisk AS, Virum, Denmark
来源：
IDRUGS | 2007年 / 10卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：606 / 609
页数：4
相关论文
共 50 条
  • [31] The Pharmacologic Basis for Clinical Differences Among GLP-1 Receptor Agonists and DPP-4 Inhibitors
    Morales, Javier
    POSTGRADUATE MEDICINE, 2011, 123 (06) : 189 - 201
  • [32] Mortality Differences SGLT-2, DPP-4 Inhibitors and GLP-1 Receptor Agonists
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 173 - 173
  • [33] Treatment with a DPP-IV inhibitor, NVP-DPP728, increases prandial intact GLP-1 levels and reduces glucose exposure in humans
    Rothenberg, P
    Kalbag, J
    Smith, H
    Gingerich, R
    Nedelman, J
    Villhauer, E
    McLeod, J
    Hughes, T
    DIABETES, 2000, 49 : A39 - A39
  • [34] 11 years of cyanopyrrolidines as DPP-IV inhibitors
    Peters, Jens-Uwe
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (06) : 579 - 595
  • [35] Antipsychotic-like effect of GLP-1 agonist liraglutide but not DPP-IV inhibitor sitagliptin in mouse model for psychosis
    Dixit, Tejashree S.
    Sharma, Ajaykumar N.
    Lucot, James B.
    Elased, Khalid M.
    PHYSIOLOGY & BEHAVIOR, 2013, 114 : 38 - 41
  • [36] SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
    El Mouhayyar, Christopher
    Riachy, Ruba
    Khalil, Abir Bou
    Eid, Asaad
    Azar, Sami
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [37] DPP-IV inhibitors: Beyond glycaemic control?
    Kwok, Andrew J.
    Mashar, Meghavi
    Khavandi, Kaivan
    Sabir, Ian
    TRENDS IN CARDIOVASCULAR MEDICINE, 2014, 24 (04) : 157 - 164
  • [38] The Place of GLP-1-Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
    Mize, Dara L. Eckerle
    Salehi, Marzieh
    CURRENT DIABETES REPORTS, 2013, 13 (03) : 307 - 318
  • [39] Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
    Aroda, Vanita R.
    Henry, Robert R.
    Han, Jenny
    Huang, Wenying
    DeYoung, Mary Beth
    Darsow, Tamara
    Hoogwerf, Byron J.
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1247 - 1258
  • [40] Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
    Neumiller, Joshua J.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 : S16 - S29
12345